REG - FTSE Russell Alliance Pharma PLC - Alliance Pharma

Alliance PharmaAnnouncement

09/05/2025 17:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250509:nRSI0649Ia&default-theme=true

RNS Number : 0649I  FTSE Russell  09 May 2025

 

Alliance Pharma (UK): Constituent Deletion

Changes in FTSE UK Index Series

09 May 2025

 Subject to court sanctioning the scheme of arrangement in relation to the cash
 offer for Alliance Pharma (UK, constituent) by Aegros Bidco Limited
 (non-constituent), please see details of affected indexes and effective dates
 below:

 

 Index                     Effective From

Start of Trading
 FTSE AIM UK 50 Index      14 May 2025
 FTSE AIM 100 Index        14 May 2025
 FTSE AIM All-Share Index  14 May 2025

 

 

 

 

 

 

 For further information please contact FTSE Russell Client Services at
 info@ftserussell.com (mailto:info@ftserussell.com) or call:

Australia  +61 (0) 2 7228 5659
 Hong Kong  +852 2164 3333
 Japan      +81 3 6441 1430
 London     +44 (0) 20 7866 1810
 New York   +1877 503 6437

 

 Alternatively please visit our website at lseg.com/ftse-russell
 (http://www.lseg.com/ftse-russell)

 Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
 © 2025 FTSE Russell

 

 

Alternatively please visit our website at lseg.com/ftse-russell
(http://www.lseg.com/ftse-russell)

 

Terms of Use (http://www.ftserussell.com/legal/website-terms-use) | Copyright
© 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  FTSKZGGKNLZGKZG